journal article·2017-01

Multifunctional Conjugated Polymer Nanoparticles for Image‐Guided Photodynamic and Photothermal Therapy

Guangxue Feng, Yuan Fang, Jie Liu, Junlong Geng, Dan Ding, Bin Liu

Small· Volume 13· Issue 3
Publisher page

Abstract

A multifunctional theranostic platform based on conjugated polymer nanoparticles (CPNs) with tumor targeting, fluorescence detection, photodynamic therapy (PDT), and photothermal therapy (PTT) is developed for effective cancer imaging and therapy. Two conjugated polymers, poly[9,9‐bis(2‐(2‐(2‐methoxyethoxy)ethoxy)‐ethyl)fluorenyldivinylene]‐alt‐4,7‐(2,1,3‐benzothiadiazole) with bright red emission and photosensitizing ability and poly[(4,4,9,9‐tetrakis(4‐(octyloxy)phenyl)‐4,9‐dihydro‐s‐indacenol‐dithiophene‐2,7‐diyl)‐alt‐co‐4,9‐bis(thiophen‐2‐yl)‐6,7‐bis(4‐(hexyloxy)phenyl)‐thiadiazolo‐quinoxaline] with strong near‐infrared absorption and excellent photothermal conversion ability are co‐loaded into one single CPN via encapsulation approach using lipid‐polyethylene glycol as the matrix. The obtained co‐loaded CPNs show sizes of around 30 nm with a high singlet oxygen quantum yield of 60.4% and an effective photothermal conversion efficiency of 47.6%. The CPN surface is further decorated with anti‐HER2 affibody, which bestows the resultant anti‐HER2‐CPNs superior selectivity toward tumor cells with HER2 overexpression both in vitro and in vivo. Under light irradiation, the PDT and PTT show synergistic therapeutic efficacy, which provides new opportunities for the development of multifunctional biocompatible organic materials in cancer therapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Photoacoustic and Ultrasonic Imaging

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical and Biomolecular Engineering National University of Singapore Singapore 117585 Singapore

State Key Laboratory of Medicinal Chemical Biology Key Laboratory of Bioactive Materials Ministry of Education, and College of Life Sciences Nankai University Tianjin 300071 P. R. China

Institute of Materials Research and Engineering (IMRE) 2 Fusionopolis Way Innovis 136834 Singapore

Funding

National Research Foundation Singapore · Institute of Materials Research and Engineering · National Natural Science Foundation of China

References (56)

Show source-provided references
1. 10.1039/B709883A10.1039/B709883A ↗
2. 10.1021/cr900236h10.1021/cr900236h ↗
3. 10.1021/cr900300p10.1021/cr900300p ↗
4. 10.1088/0957-4484/20/13/13510210.1088/0957-4484/20/13/135102 ↗
5. 10.1016/j.biomaterials.2011.01.03210.1016/j.biomaterials.2011.01.032 ↗
6. 10.1016/j.addr.2003.09.00310.1016/j.addr.2003.09.003 ↗
7. 10.1038/nm.255410.1038/nm.2554 ↗
8. 10.1021/jp051163i10.1021/jp051163i ↗
9. 10.1021/ja504279r10.1021/ja504279r ↗
10. 10.1054/bjoc.2001.217010.1054/bjoc.2001.2170 ↗
11. Vrouenraets M. B. · Cancer Res. · 2001 · 61 · 1970
12. 10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗
13. 10.1016/j.jconrel.2008.04.01610.1016/j.jconrel.2008.04.016 ↗
14. 10.1016/j.jconrel.2007.09.00210.1016/j.jconrel.2007.09.002 ↗
15. 10.1016/j.msec.2015.08.00610.1016/j.msec.2015.08.006 ↗
16. 10.1002/anie.20100603810.1002/anie.201006038 ↗
17. Jalili A. · Am. Assoc. Cancer Res. · 2004 · 10 · 4498
18. 10.1093/jnci/91.18.155710.1093/jnci/91.18.1557 ↗
19. 10.1021/nn305011p10.1021/nn305011p ↗
20. 10.1021/ar200017e10.1021/ar200017e ↗
21. 10.1039/C1CS15166E10.1039/C1CS15166E ↗
22. 10.1021/nl050127s10.1021/nl050127s ↗
23. 10.1021/ja801631c10.1021/ja801631c ↗
24. 10.1021/nl100996u10.1021/nl100996u ↗
25. 10.1016/j.biomaterials.2011.05.00710.1016/j.biomaterials.2011.05.007 ↗
26. 10.1002/adfm.20140145110.1002/adfm.201401451 ↗
27. 10.1002/adma.20110471410.1002/adma.201104714 ↗
28. 10.1021/nn401168610.1021/nn4011686 ↗
29. 10.1021/cr200263w10.1021/cr200263w ↗
30. 10.1021/cm102196t10.1021/cm102196t ↗
31. 10.1021/cr050133910.1021/cr0501339 ↗
32. 10.1021/nn304376z10.1021/nn304376z ↗
33. 10.1002/smll.20140209210.1002/smll.201402092 ↗
34. 10.1039/c3py01587d10.1039/c3py01587d ↗
35. 10.1002/smll.20130017110.1002/smll.201300171 ↗
36. 10.1002/anie.20140218910.1002/anie.201402189 ↗
37. 10.1021/nn301539m10.1021/nn301539m ↗
38. 10.1002/adfm.20150108110.1002/adfm.201501081 ↗
39. 10.1002/smll.20130216110.1002/smll.201302161 ↗
40. 10.1002/adfm.20090109810.1002/adfm.200901098 ↗
41. 10.1002/anie.20120513310.1002/anie.201205133 ↗
42. 10.1039/C4CS00014E10.1039/C4CS00014E ↗
43. 10.1002/smll.20130350510.1002/smll.201303505 ↗
44. 10.1002/anie.20100426010.1002/anie.201004260 ↗
45. 10.1158/0008-5472.CAN-05-042610.1158/0008-5472.CAN-05-0426 ↗
46. 10.1158/0008-5472.CAN-05-352110.1158/0008-5472.CAN-05-3521 ↗
47. 10.1021/ac102949u10.1021/ac102949u ↗
48. 10.1021/nn103526210.1021/nn1035262 ↗
49. 10.1038/ncomms559610.1038/ncomms5596 ↗
50. 10.1021/jp064341w10.1021/jp064341w ↗
51. 10.1021/nl201400z10.1021/nl201400z ↗
52. 10.1021/nn203293t10.1021/nn203293t ↗
53. 10.1158/0008-5472.CAN-06-163010.1158/0008-5472.CAN-06-1630 ↗
54. 10.1021/nn900002m10.1021/nn900002m ↗
55. 10.1021/mp800049w10.1021/mp800049w ↗
56. 10.1158/0008-5472.CAN-08-146810.1158/0008-5472.CAN-08-1468 ↗